Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Szwed, J. J.
Right arrow Articles by Kleit, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szwed, J. J.
Right arrow Articles by Kleit, S. A.
(Chest. 1974;66:278-281.)
© 1974 American College of Chest Physicians

Effect of Hemodialysis on Oxygen-Hemoglobin Affinity in Chronic Uremics

James J. Szwed M.D.1; Friedrich C. Luft M.D.2; John R. Boykin M.D.2; Mark O. Farber M.D.2; and Stuart A. Kleit M.D.2

1 Recipient of grants-in-aid from Eli Lilly Company and Indiana Kidney Foundation
2 Departments of Medicine, Indiana University and Veterans Administration Hospital, Pulmonary Research Laboratories, Indianapolis

P50, plasma pH, red cell pH, 2,3-DPG, ATP, lactate, pyruvate, and glycolytic rate were measured before and after hemodialysis in 25 patients on chronic hemodialysis, The prehemodialysis—resting 2,3-DPG level and P50 were elevated in accordance with the degree of anemia. The resting lactate and glycolytic rate were mildly elevated. Plasma and red cell pH increased significantly with dialysis. The in vivo P50 decreased significantly, whereas the in vitro P50, 2,3-DPG, and ATP levels remained constant. The fall in the in vivo P50 can be attributed entirely to the rise in red cell pH or Bohr effect. The decrease in the in vivo P50 during hemodialysis may transiently impair oxygen oxygen delivery in these Patients. Marked shifts in pH, especially into the alkalemic range, should be minimized, particularly in patients undergoing frequent or prolonged hemodialysis.

Submitted on March 11, 1974
Accepted on April 23, 1974







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1974 by the American College of Chest Physicians.